Denbinobin suppresses breast cancer metastasis through the inhibition of Src-mediated signaling pathways

Journal of Nutritional Biochemistry

Volumn 22, Issue 8, 2011, Pages 732-740

  Chen, Pei Hsuan ^a   Peng, Chieh Yu ^a   Pai, Hui Chen ^a   Teng, Che Ming ^a   Chen, Chien Chih ^b   Yang, Chia Ron ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b HUNGKUANG UNIVERSITY   (Taiwan)

Author keywords

Breast cancer; Denbinobin; Metastasis; Migration; Natural products; Src

Indexed keywords

ANTINEOPLASTIC AGENT; CRK ASSOCIATED SUBSTRATE PROTEIN; DENBINOBIN; FOCAL ADHESION KINASE; HERBACEOUS AGENT; PROTEIN KINASE; SRC KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST METASTASIS; CANCER CELL; CANCER INHIBITION; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EPHEMERANTHA LONCHOPHYLLA; HUMAN; HUMAN CELL; IN VITRO STUDY; MEDICINAL PLANT; MOLECULAR MECHANICS; MOUSE; NONHUMAN; SPLENOMEGALY; TUMOR VOLUME;

ANIMALS; ANTHRAQUINONES; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CRK-ASSOCIATED SUBSTRATE PROTEIN; FEMALE; FOCAL ADHESION KINASE 1; HUMANS; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; PAXILLIN; PHENANTHRENES; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TRANSFECTION;

EPHEMERANTHA LONCHOPHYLLA;

EID: 79960318305     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.06.004     Document Type: Article

References (47)

1. Yoshida B.A., Sokoloff M.M., Welch D.R., Rinker-Schaeler C.W. Metastasis-suppressor genes: a review and perspective. J Natl Cancer Inst 2000, 92:1717-1730.
2. Woodhouse E.C., Chuaqui R.F., Liotta L.A. General mechanisms of metastasis. Cancer 1997, 80:1529-1537.
3. Shih J.Y., Yang S.C., Hong T.M., Yuan A., Chen J.J., Yu C.J., et al. Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells. J Natl Cancer Inst 2001, 93:1392-1400.
4. Hiscox S., Nicholson R.I. Src inhibitors in breast cancer therapy. Expert Opin Ther Targets 2008, 12:757-767.
5. Finn R.S. Targeting Src in breast cancer. Ann Oncol 2008, 19:1379-1386.
6. Zhu S., Bjorge J.D., Cheng H.C., Fujita D.J., Decreased C.H.K. protein levels are associated with Src activation in colon cancer cells. Oncogene 2008, 27:2027-2034.
7. Myoui A., Nishimura R., Williams P.J., Hiraga T., Tamura D., Michigami T., et al. C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis. Cancer Res 2003, 63:5028-5033.
8. Ichihara N., Kubota Y., Kitanaka A., Tanaka T., Taminato T. Inhibition of Src reduces gemcitabine-induced cytotoxicity in human pancreatic cancer cell lines. Cancer Lett 2008, 260:155-162.
9. Ishizawar R., Parsons S.J. c-Src and cooperating partners in human cancer. Cancer Cell 2004, 6:209-214.
10. Frame M.C. Newest findings on the oldest oncogene; how activated Src does it. J Cell Sci 2004, 117:989-998.
11. Yeatman T.J. A renaissance for Src. Nat Rev Cancer 2004, 4:470-480.
12. Weis S., Cui J., Barnes L., Cheresh D. Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis. J Cell Biol 2004, 167:223-229.
13. Chou M.T., Wang J., Fujita D.J. Src kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells. BMC Biochem 2002, 3:32-42.
14. Palmer A., Zimmer M., Erdmann K.S., Eulenburg V., Porthin A., Heumann R., et al. EphrinB phosphorylation and reverse signaling: regulation by Src kinases and PTP-BL phosphatase. Mol Cell 2002, 9:725-737.
15. Bromann P.A., Korkaya H., Courtneidge S.A. The interplay between Src family kinases and receptor tyrosine kinases. Oncogene 2004, 23:7957-7968.
16. Playford M.P., Schaller M.D. The interplay between Src and integrins in normal and tumor biology. Oncogene 2004, 23:7928-7946.
17. Gonzalez L., Agullo-Ortuno M.T., Garcia-Martinez J.M., Calcabrini A., Gamallo C., Palacios J., et al. Role of c-Src in human MCF7 breast cancer cell tumorigenesis. J Biol Chem 2006, 281:20851-20864.
18. Lee Y.H., Park J.D., Baek N.I., Kim S.I., Ahn B.Z. In vitro and in vivo antitumoral phenanthrenes from the aerial parts of Dendrobium nobile. Planta Med 1995, 61:178-180.
19. Chen H.Y., Shiao M.S., Huang Y.L., Shen C.C., Lin Y.L., Kuo Y.H., et al. Antioxidant principles from Ephemerantha lonchophylla. J Nat Prod 1999, 62:1225-1227.
20. Lin T.H., Chang S.J., Chen C.C., Wang J.P., Tsao L.T. Two phenanthraquinones from Dendrobium moniliforme. J Nat Prod 2001, 64:1084-1086.
21. Huang Y.C., Guh J.H., Teng C.M. Denbinobin-mediated anticancer effect in human K562 leukemia cells: role in tubulin polymerization and Bcr-Abl activity. J Biomed Sci 2005, 12:113-121.
22. Kuo C.T., Chen B.C., Yu C.C., Weng C.M., Hsu M.J., Chen C.C., et al. Apoptosis signal-regulating kinase 1 mediates denbinobin-induced apoptosis in human lung adenocarcinoma cells. J Biomed Sci 2009, 16:43.
23. Chen T.H., Pan S.L., Guh J.H., Chen C.C., Huang Y.T., Pai H.C., et al. Denbinobin induces apoptosis by apoptosis-inducing factor releasing and DNA damage in human colorectal cancer HCT-116 cells. Naunyn Schmiedebergs Arch Pharmacol 2008, 378:447-457.
24. Thomas S.M., Brugge J.S. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 1997, 13:513-609.
25. Park E.J., Min H.Y., Chung H.J., Hong J.Y., Kang Y.J., Hung T.M., et al. Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells. Cancer Lett 2009, 277:133-140.
26. Zhou Q., Shaw P.G., Davidson N.E. Inhibition of histone deacetylase suppresses EGF signaling pathways by destabilizing EGFR mRNA in ER-negative human breast cancer cells. Breast Cancer Res Treat 2009, 117:443-451.
27. Trevino J.G., Summy J.M., Gallick G.E. Src inhibitors as potential therapeutic agents for human cancers. Mini Rev Med Chem 2006, 6:681-687.
28. McLean G.W., Carragher N.O., Avizienyte E., Evans J., Brunton V.G., Frame M.C. The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nat Rev Cancer 2005, 5:505-515.
29. Sharma A., Mayer B.J. Phosphorylation of p130Cas initiates Rac activation and membrane ruffling. BMC Cell Biol 2008, 9:50.
30. Brown M.C., Turner C.E. Paxillin: adapting to change. Physiol Rev 2004, 84:1315-1339.
31. Fox E.M., Bernaciak T.M., Wen J., Weaver A.M., Shupnik M.A., Silva C.M. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells. Mol Endocrinol 2008, 22:1781-1796.
32. Choi S., Lee S.A., Kwak T.K., Kim H.J., Lee M.J., Ye S.K., et al. Cooperation between integrin alpha5 and tetraspan TM4SF5 regulates VEGF-mediated angiogenic activity. Blood 2009, 113:1845-1855.
33. Leroy C., Fialin C., Sirvent A., Simon V., Urbach S., Poncet J., et al. Quantitative phosphoproteomics reveals a cluster of tyrosine kinases that mediates SRC invasive activity in advanced colon carcinoma cells. Cancer Res 2009, 69:2279-2286.
34. Jallal H., Valentino M.L., Chen G., Boschelli F., Ali S., Rabbani S.A.A. Src/Abl kinase inhibitor, SKI-606, blocks breast cancer invasion, growth, and metastasis in vitro and in vivo. Cancer Res 2007, 67:1580-1588.
35. Santen R.J., Fan P., Zhang Z., Bao Y., Song R.X., Yue W. Estrogen signals via an extra-nuclear pathway involving IGF-1R and EGFR in tamoxifen-sensitive and -resistant breast cancer cells. Steroids 2009, 74:586-594.
36. Soysa N.S., Alles N., Shimokawa H., Jimi E., Aoki K., Ohya K. Inhibition of the classical NF-kappaB pathway prevents osteoclast bone-resorbing activity. J Bone Miner Metab 2009, 27:131-139.
37. Vultur A., Buettner R., Kowolik C., Liang W., Smith D., Boschelli F., et al. SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells. Mol Cancer Ther 2008, 7:1185-1194.
38. von Sengbusch A., Gassmann P., Fisch K.M., Enns A., Nicolson G.L., Haier J. Focal adhesion kinase regulates metastatic adhesion of carcinoma cells within liver sinusoids. Am J Pathol 2005, 166:585-596.
39. Van der Voort van Zyp J., Thamilselvan V., Walsh M., Polin L., Basson M.D. Extracellular pressure stimulates colon cancer cell adhesion in vitro and to surgical wounds by Src (sarcoma protein) activation. Am J Surg 2004, 188:467-473.
40. Basson M.D. An intracellular signal pathway that regulates cancer cell adhesion in response to extracellular forces. Cancer Res 2008, 68:2-4.
41. Watermann D.O., Gabriel B., Jager M., Orlowska-Volk M., Hasenburg A., zur Hausen A., et al. Specific induction of pp125 focal adhesion kinase in human breast cancer. Br J Cancer 2005, 93:694-698.
42. Brunton V.G., Avizienyte E., Fincham V.J., Serrels B., Metcalf C.A., Sawyer T.K., et al. Identification of Src-specific phosphorylation site on focal adhesion kinase: dissection of the role of Src SH2 and catalytic functions and their consequences for tumor cell behavior. Cancer Res 2005, 65:1335-1342.
43. Sachdev S., Bu Y., Gelman I.H. Paxillin-Y118 phosphorylation contributes to the control of Src-induced anchorage-independent growth by FAK and adhesion. BMC Cancer 2009, 9:12.
44. Schaller M.D. Paxillin: a focal adhesion-associated adaptor protein. Oncogene 2001, 20:6459-6472.
45. Tao K., Fang M., Alroy J., Sahagian G.G. Imagable 4T1 model for the study of late stage breast cancer. BMC Cancer 2008, 8:228.
46. Bibby M.C. Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages. Eur J Cancer 2004, 40:852-857.
47. Vernon A.E., Bakewell S.J., Chodosh L.A. Deciphering the molecular basis of breast cancer metastasis with mouse models. Rev Endocr Metab Disord 2007, 8:199-213.